FHIR IG analytics| Package | fhir.ke.nccp |
| Resource Type | CodeSystem |
| Id | CodeSystem-sha-interventions-cs.json |
| FHIR Version | R4 |
| Source | https://build.fhir.org/ig/IntelliSOFT-Consulting/nccpFHIRIG/CodeSystem-sha-interventions-cs.html |
| URL | https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs |
| Version | 0.1.0 |
| Status | active |
| Date | 2026-06-08T10:30:33+00:00 |
| Name | SHAInterventionsCS |
| Title | Kenya SHA Oncology Interventions Code System |
| Realm | us |
| Authority | hl7 |
| Description | Social Health Authority (SHA) benefit package codes for oncology interventions. |
| Content | complete |
| ValueSet | ||
| fhir.ke.nccp#current | nccp-sha-interventions-vs | Kenya SHA Oncology Interventions Value Set |
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: CodeSystem sha-interventions-cs
This case-sensitive code system https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs defines the following codes:
{
"resourceType": "CodeSystem",
"id": "sha-interventions-cs",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs",
"version": "0.1.0",
"name": "SHAInterventionsCS",
"title": "Kenya SHA Oncology Interventions Code System",
"status": "active",
"experimental": false,
"date": "2026-06-08T10:30:33+00:00",
"publisher": "Digital Health Agency (DHA), Kenya",
"contact": [
{
"name": "Digital Health Agency (DHA), Kenya",
"telecom": [
{
"system": "url",
"value": "https://dha.go.ke"
},
{
"system": "email",
"value": "info@dha.go.ke"
}
]
},
{
"name": "Digital Health Agency Kenya – FHIR Team",
"telecom": [
{
"system": "email",
"value": "info@dha.go.ke",
"use": "work"
},
{
"system": "url",
"value": "https://dha.go.ke",
"use": "work"
}
]
}
],
"description": "Social Health Authority (SHA) benefit package codes for oncology interventions.",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "KE",
"display": "Kenya"
}
]
}
],
"caseSensitive": true,
"content": "complete",
"count": 30,
"concept": [
{
"code": "SHA-CHEMO-FIRST-LINE",
"display": "SHA: Chemotherapy — First Line",
"definition": "First-line chemotherapy regimen."
},
{
"code": "SHA-CHEMO-SECOND-LINE",
"display": "SHA: Chemotherapy — Second Line",
"definition": "Second-line or salvage chemotherapy."
},
{
"code": "SHA-CHEMO-ADJUVANT",
"display": "SHA: Chemotherapy — Adjuvant",
"definition": "Post-surgery adjuvant chemotherapy."
},
{
"code": "SHA-CHEMO-NEO-ADJUVANT",
"display": "SHA: Chemotherapy — Neo-adjuvant",
"definition": "Pre-surgery neo-adjuvant chemotherapy."
},
{
"code": "SHA-CHEMO-PALLIATIVE",
"display": "SHA: Chemotherapy — Palliative",
"definition": "Palliative intent chemotherapy."
},
{
"code": "SHA-RT-RADICAL",
"display": "SHA: Radiotherapy — Radical",
"definition": "Curative radiotherapy course."
},
{
"code": "SHA-RT-PALLIATIVE",
"display": "SHA: Radiotherapy — Palliative",
"definition": "Palliative radiotherapy course."
},
{
"code": "SHA-RT-ADJUVANT",
"display": "SHA: Radiotherapy — Adjuvant",
"definition": "Post-surgery adjuvant radiotherapy."
},
{
"code": "SHA-RT-CONCURRENT-CRT",
"display": "SHA: Concurrent Chemo-Radiotherapy",
"definition": "Chemotherapy and radiotherapy delivered concurrently."
},
{
"code": "SHA-SURGERY-CURATIVE",
"display": "SHA: Surgery — Curative",
"definition": "Cancer surgery with curative intent."
},
{
"code": "SHA-SURGERY-PALLIATIVE",
"display": "SHA: Surgery — Palliative",
"definition": "Palliative or debulking surgery."
},
{
"code": "SHA-BMT-AUTOLOGOUS",
"display": "SHA: BMT — Autologous",
"definition": "Autologous bone marrow / stem cell transplant."
},
{
"code": "SHA-BMT-ALLOGENEIC",
"display": "SHA: BMT — Allogeneic",
"definition": "Allogeneic bone marrow / stem cell transplant."
},
{
"code": "SHA-HORMONAL-THERAPY",
"display": "SHA: Hormonal Therapy",
"definition": "Hormone therapy for hormone-responsive cancers."
},
{
"code": "SHA-TARGETED-THERAPY",
"display": "SHA: Targeted Therapy",
"definition": "Targeted molecular therapy / immunotherapy."
},
{
"code": "SHA-SUPPORTIVE-CARE",
"display": "SHA: Supportive / Supportive Care",
"definition": "Supportive medications and G-CSF."
},
{
"code": "SHA-PAIN-MANAGEMENT",
"display": "SHA: Palliative Pain Management",
"definition": "Opioid and pain management for cancer."
},
{
"code": "SHA-CANCER-SCREENING",
"display": "SHA: Cancer Screening",
"definition": "Covered cancer screening tests (cervical, breast)."
},
{
"code": "SHA-BIOPSY",
"display": "SHA: Diagnostic Biopsy",
"definition": "Tissue biopsy for cancer diagnosis."
},
{
"code": "SHA-IMAGING",
"display": "SHA: Oncology Diagnostic Imaging",
"definition": "CT, MRI, PET-CT for staging or response."
},
{
"code": "SHA-ONCOLOGY-CONSULT",
"display": "SHA: Oncology Consultation",
"definition": "Specialist oncology consultation."
},
{
"code": "SHA-MDT",
"display": "SHA: MDT Meeting",
"definition": "Multidisciplinary tumour board review."
},
{
"code": "SHA-PATHOLOGY",
"display": "SHA: Pathology / Histopathology",
"definition": "Histopathology, IHC, or molecular diagnostics."
},
{
"code": "SHA-RT-DOSE-PER-FRACTION",
"display": "SHA: RT Dose Per Fraction",
"definition": "Radiation dose delivered per fraction (Gy)."
},
{
"code": "SHA-RT-TOTAL-FRACTIONS",
"display": "SHA: RT Total Fractions Delivered",
"definition": "Total number of radiation fractions delivered."
},
{
"code": "SHA-SUSPECTED-CANCER-TYPE",
"display": "SHA: Suspected Cancer Type",
"definition": "Type of cancer suspected at screening/referral."
},
{
"code": "SHA-SUSPICION-LEVEL",
"display": "SHA: Cancer Suspicion Level",
"definition": "Clinical level of suspicion for malignancy."
},
{
"code": "SHA-REASON-FOR-SUSPICION",
"display": "SHA: Reason for Suspicion",
"definition": "Reason underpinning the cancer suspicion."
},
{
"code": "SHA-PRESENTING-SYMPTOMS",
"display": "SHA: Presenting Symptoms",
"definition": "Symptoms presented by the patient."
},
{
"code": "SHA-DIAGNOSTIC-WORKUP",
"display": "SHA: Planned Diagnostic Workup",
"definition": "Diagnostic investigations planned for confirmation."
}
]
}